Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: The A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal)

Thrombosis Research

Volumn 122, Issue 5, 2008, Pages 648-656

  Freitas, Ana I ^a   Mendonça, Isabel ^b   Guerra, Graça ^a   Brión, Maria ^c   Reis, Roberto P ^d   Carracedo, Angel ^c   Brehm, António ^a  

^a UNIVERSITY OF MADEIRA   (Portugal)

^b HOSPITAL CENTRAL DO FUNCHAL   (Portugal)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^d UNIVERSIDADE NOVA DE LISBOA   (Portugal)

Author keywords

Coronary artery disease; Gene polymorphisms; Homocysteine; MTHFR

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PORTUGAL; PRIORITY JOURNAL; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PORTUGAL; RISK FACTORS;

EID: 49549086902     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.02.005     Document Type: Article

References (52)

1. Clarke R., Daly L., Robinson K., Naughten E., Cahalane S., Fowler B., et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324 (1991) 1149-1155
2. Stampfer M.J., Malinow M.R., Willett W.C., Newcomer L.M., Upson B., Ullmann D., et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 268 (1992) 877-881
3. Boushey C.J., Beresford S.A., Omenn G.S., and Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274 (1995) 1049-1057
4. Motulsky A.G. Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. Am J Hum Genet 58 (1996) 17-20
5. Kang S.S., Wong P.W., and Norusis M. Homocysteinemia due to folate deficiency. Metabolism 36 (1987) 458-462
6. Ubbink J.B., Vermaak W.J., van der Merwe A., and Becker P.J. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr 57 (1993) 47-53
7. Brattstrom L., Wilcken D.E., Ohrvik J., and Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation 98 (1998) 2520-2526
8. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Metthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10 (1995) 111-113
9. Kluijtmans L.A., Kastelein J.J., Lindemans J., Boers G.H., Heil S.G., Bruschke A.V., et al. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation 96 (1997) 2573-2578
10. Arruda V.R., von Zuben P.M., Chiaparini L.C., Annichino-Bizzacchi J.M., and Costa F.F. The mutation Ala677àVal in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb Haemost 77 (1997) 818-821
11. Brugada R., and Marian A.J. A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction. Atherosclerosis 128 (1997) 107-112
12. Meisel C., Cascorbi I., Gerloff T., Stangl V., Laule M., Muller J.M., et al. Identification of six methylenetetrahydrofolate reductase (MTHFR) genotypes resulting from common polymorphisms: impact on plasma homocysteine levels and development of coronary artery disease. Atherosclerosis 154 (2001) 651-668
13. Anderson J.L., King G.J., Thomson M.J., Todd M., Bair T.L., Muhlestein J.B., et al. A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction. J Am Coll Cardiol 30 (1997) 1206-1211
14. Klerk M., Verhoef P., Clarke R., Blom H.J., Kok F.J., and Schouten E.G. MTHFR studies collaboration group. MTHFR 677C→T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 288 (2002) 2023-2031
15. van der Put N.M., Gabreels F., Stevens E.M., Smeitink J.A., Trijbels F.J., Eskes T.K., et al. A second mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neutral tube defects?. Am J Hum Genet 62 (1998) 1044-1051
16. Viel A., Dall'Agnese L., Simone F., Canzonieri V., Capozzi E., Visentin M.C., et al. Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas. Br J Cancer 75 (1997) 1105-1110
17. Weisberg I.S., Jacques P.F., Selhub J., Bostom A.G., Chen Z., Curtis Ellison R., et al. The 1298A3C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis 156 (2001) 409-415
18. Kowa H., Yasui K., Takeshima T., Urakami K., Sakai F., and Nakashima K. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet 96 (2000) 762-764
19. Skibola C.F., Smith M.T., Kane E., Roman E., Rollinson S., Cartwright R.A., et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 96 (1999) 12810-12815
20. Raymont M., and Rousset F. GENEPOP (V.1.2) A population genetics software for exact tests and ecumenicism. J Hered 95 (1995) 248-249
21. Schneider S., Kueffer J.M., and Roessli D. Arlequin: a software for population genetic data analysis. Genetics and Biometry Laboratory (2000), University of Geneva, Switzerland
22. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68 (2001) 978-989
23. Weir B., and Cockerham C. Estimating F-statistics for the analysis of population structure. Evolution 38 (1984) 1358-1370
24. Goudet J. FSTAT, a program to estimate and test gene diversities and fixation indices (version 2.9.3). 2001. Available from www.unil.ch/izea/softwares/fstat.html. Updated from Goudet (1995).
25. Rice W.R. Analyzing tables of statistical tests. Evolution 43 (1989) 223-225
26. Mendonça I., Freitas A.I., Sousa A.C., Gomes S., Faria P., Drumond A., et al. Polymorphism of the ACE gene is associated with extent and severity of coronary disease. Rev Port Cardiol 23 (2004) 1605-1611
27. Nei M. Molecular Evolutionary Genetics (2000), Columbia University Press, New York
28. Nygard O., Vollset S.E., Refsum H., Stensvold I., Tverdal A., Nordrehaug J.E., et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 274 (1995) 1526-1533
29. Folsom A.R., Nieto F.J., McGovern P.G., Tsai M.Y., Malinow M.R., Eckfeldt J.H., et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 98 (1998) 204-210
30. Evans R.W., Shaten B.J., Hempel J.D., Cutler J.A., and Kuller L.H. Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial. Arterioscler Thromb Vasc Biol 17 (1997) 1947-1953
31. Fonseca V., Guba S.C., and Fink L.M. Hyperhomocysteinemia and the endocrine system: implications for atherosclerosis and thrombosis. Endocr Rev 20 (1999) 738-759
32. Alam M.A., Husain S.A., Narang R., Chauhan S.S., Kabra M., and Vasisht S. Association of polymorphism in the thermolabile 5,10-methylene tetrahydrofolate reductase gene and hyperhomocysteinemia with coronary artery disease. Mol Cell Biochem 310 (2007) 111-117
33. Bennouar N., Allami A., Azeddoug H., Bendris A., Laraqui A., El Jaffali A., et al. Thermolabile methylenetetrahydrofolate reductase C677T polymorphism and homocysteine are risk factors for coronary artery disease in Moroccan population. J Biomed Biotechnol (2007) [Electronic Publication]
34. Laraqui A., Allami A., Carrié A., Raisonnier A., Coiffard A.S., Benkouka F., et al. Relation between plasma homocysteine, gene polymorphisms of homocysteine metabolism-related enzymes, and angiographically proven coronary artery disease. Eur J Intern Med 18 (2007) 474-483
35. Kölling K., Ndrepepa G., Koch W., Braun S., Mehilli J., Schömig A., et al. Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms, plasma homocysteine, folate, and vitamin B12 levels and the extent of coronary artery disease. Am J Cardiol. 93 (2004) 1201-1206
36. Eikelboom J.W., Lonn E., Genest Jr. J., Hankey G., and Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 131 (1999) 363-375
37. Thambyrajah J., and Townend J.N. Homocysteine and atherothrombosis-mechanisms for injury. Eur Heart J 21 (2000) 967-974
38. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest 98 (1996) 5-7
39. Fenech M. The role of folic acid and vitamin B12 in genomic stability of human cells. Mutat Res 475 (2001) 57-67
40. Yi P., Melnyk S., Pogribna M., Pogribny I.P., Hine R.J., and James S.J. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 275 (2000) 29318-29323
41. Passaro A., Vanini A., Calzoni F., Alberti L., Zamboni P.F., Fellin R., et al. Plasma homocysteine, methylenetetrahydrofolate reductase mutation and carotid damage in elderly healthy women. Atherosclerosis 157 (2001) 175-180
42. Gudnason V., Stansbie D., Scott J., Bowron A., Nicaud V., and Humphries S. C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations. EARS group. Atherosclerosis 136 (1998) 347-354
43. Botto N., Andreassi M.G., Manfredi S., Masetti S., Cocci F., Colombo M.G., et al. Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage. Eur J Hum Genet 11 (2003) 671-678
44. Hanson N.Q., Omer A., Yang F., and Tsai M.Y. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. Clin Chem 47 (2001) 661-666
45. Malinow M.R., Willett W.C., and Rozen R. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 94 (1996) 2410-2416
46. Ma J., Stampfer M.J., Hennekens C.H., Frosst P., Selhub J., Horsford J., et al. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 94 (1996) 2410-2416
47. van Bockxmeer F.M., Mamotte C.D., Vasikaran S.D., and Taylor R.R. Methylenetetrahydrofolate reductase gene and coronary artery disease. Circulation 95 (1997) 21-23
48. Falchi A., Giovannoni L., Piras I.S., Calo C.M., Moral P., Vona G., et al. Prevalence of genetic risk factors for coronary artery disease in Corsica island (France). Exp Mol Path 79 (2005) 210-213
49. Weisberg I., Tran P., Christensen B., Sibani S., and Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64 (1998) 169-172
50. Franco R.F., Morelli V., Lourenco D., Maffei F.H., Tavella M.H., Piccinato C.E., et al. A second mutation in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease. Br J Haematol 105 (1999) 556-559
51. Rady P.L., Tyring S.K., Hudnall S.D., Vargas T., Kellner L.H., Nitowsky H., et al. Methylenetetrahydrofolate reductase (MTHFR): the incidence of mutations C677T and A1298C in the Ashkenazi Jewish population. Am J Med Genet 86 (1999) 380-384
52. Isotalo P.A., Wells G.A., and Donnelly J.G. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations. Am J Hum Genet 67 (2000) 986-990